NovoCure Limited (NVCR)
(Delayed Data from NSDQ)
$23.15 USD
+0.84 (3.77%)
Updated May 24, 2024 03:59 PM ET
After-Market: $23.15 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/25/2024
Time: -- |
6/2024 | $-0.41 | 2.31% |
Earnings Summary
For their last quarter, NovoCure Limited (NVCR) reported earnings of -$0.36 per share, beating the Zacks Consensus Estimate of $-0.43 per share. This reflects a positive earnings surprise of 16.28%. Look out for NVCR's next earnings release expected on July 25, 2024. For the next earning release, we expect the company to report earnings of -$0.41 per share, reflecting a year-over-year increase of 24.07%.
Earnings History
Price & Consensus
Zacks News for NVCR
Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store?
NVCR: What are Zacks experts saying now?
Zacks Private Portfolio Services